Multi-factor intervention in first-episode patients with type 2 diabetes mellitus common carotid artery intima-media thickness of.doc

 PAGE \* MERGEFORMAT 16 Multi-factor intervention in first-episode patients with type 2 diabetes mellitus common carotid artery intima-media thickness of Author: LIU Yu-ping HUANG Xiu-juan Huang Jiao Xiong Bin Wong Cheuk-lun Lai Xiaohui Chen Weikun 【Abstract】 Objective To strengthen the multi-factor intervention in first-episode patients with type 2 diabetes mellitus common carotid artery, the thickness of film thickness. Methods 90 patients with type 2 diabetes patients starting multi-factor enhanced therapeutic intervention to interfere with the common carotid artery before and after, the difference in thickness ≥ 0.02 mm as the limit of thickening of the patients were divided into groups of 24 cases and non-thickening Section 66 cases were compared metabolism and its relationship with common carotid artery, medial thickening of relationship. Results thickening group smoking, drinking, high blood cholesterol, high blood pressure ratio and the average age of the history were significantly higher than non-thickened group (P lt;0.05); enhanced therapeutic intervention 1 a the end of the two groups of fasting plasma glucose, glycated hemoglobin, triglycerides, total cholesterol, high density lipoprotein cholesterol, low-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, body mass index, 24 h urinary albumin were significantly lower than that before intervention (P lt;0.05 or 0.01) . Logistic regression analysis, the common carotid artery, intima thickness and age, glycated hemoglobin, high-sensitivity C  reactive protein and other factors closely related. Conclusions Type 2 diabetes patients starting a comprehensive intervention to strengthen the earlier the decline in blood glucose more significantly, the common carotid artery, the slower progress in the membrane thickness. Keywords: Type 2 diabetes mellitus; common carotid artery, in the film; glycosylated hemoglobin; high-sensitivity C  reactive protein;